SAR 31.95
(2.4%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 115.25 Million SAR | 62.41% |
2022 | 70.96 Million SAR | 37.35% |
2021 | 51.67 Million SAR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 45.73 Million SAR | -0.36% |
2023 Q2 | 39.88 Million SAR | 3.36% |
2023 Q4 | 45.9 Million SAR | 15.09% |
2023 FY | 115.25 Million SAR | 62.41% |
2022 Q2 | 33.99 Million SAR | 0.0% |
2022 FY | 70.96 Million SAR | 37.35% |
2022 Q4 | 38.58 Million SAR | 13.51% |
2021 FY | 51.67 Million SAR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 128.79 Million SAR | 10.51% |
Al-Dawaa Medical Services Company | 1.59 Billion SAR | 92.787% |
Nahdi Medical Company | 2.47 Billion SAR | 95.343% |
Al-Razi Medical Co. | 12.26 Million SAR | -840.007% |